The Parkinson’s Pipeline 2011: Treating Your Parkinson’s

Tuesday, April 12, 2011
01:00 PM to 02:00 PM
EDT

Each person experiences Parkinson’s differently.  So why should we treat each person the same exact way? Find out more by viewing this one-hour online seminar led by Michael Schlossmacher, M.D., of the University of Ottawa in Canada. In this seminar, Dr. Schlossmacher discusses new ways of looking at the pipeline of experimental treatments for Parkinson’s, in particular the potential role of personalized treatments.

View this PD ExpertBriefing Now

Download Slides (may take several minutes)

Learning Objectives: 
  • Become familiar with biomarkers for Parkinson’s: what they are; how they will help scientists to diagnose and track a person’s disease; and how they will help us to develop personalized treatments.
  • Understand how studying (and treating) “sub-groups” of people living with Parkinson’s is important for clinical trials to succeed.
  • Learn about the strong link between Parkinson’s disease and the Gaucher disease gene and what it means for drug trials. People living with typical Parkinson’s have a 10-12 percent chance of carrying a mutation in this gene.
Faculty: 
Michael Schlossmacher , M.D. , Associate Professor, Medicine (Neurology), Departments of Cellular and Molecular Medicine, University of Ottawa

Dr. Schlossmacher  is Associate Professor of Medicine (Neurology) in both the Departments of Cellular and Molecular Medicine at the University of Ottawa. He is also a practicing scientist within the neuroscience department at Ottawa Hospital Research Institute and an attending neurologist in the Division of Neurology at The Ottawa Hospital. Dr. Schlossmacher also serves as Canada Research Chair in Parkinson Disease (tier II).

Questions? CEUs?

If you have questions about how to join this PD ExpertBriefing, by phone or online, please see our PD ExpertBriefing FAQ.

Are you a health care professional seeking continuing education units? CEUs are provided via PDF’s sponsorship of the American Society on Aging. When registering for this PD ExpertBriefing, please be sure to indicate interest in CEUs. Health professionals have 30 days in which to view the live or recorded seminar and apply for CEUs. It may take an additional 30 days to process CEUs.

Other Seminars

Browse our library of past seminars and watch them at any time to learn more about nutrition, the PD pipeline and other topics.

This series has been made possible by educational grants from AbbVie, Inc., ACADIA Pharmaceuticals Inc. and Lundbeck LLC.

It is designed in collaboration with Dallas Area Parkinsonism Society (DAPS); Houston Area Parkinson Society (HAPS); Michigan Parkinson Foundation (MPF); the Neuro Challenge Foundation (NCF); Parkinson Association of the Carolinas (PAC); Parkinson Association of the Rockies (PAR); Parkinson's Association (PA) and Parkinson Support Center of Kentuckiana (PSCKY).